Location of Repository

EFFICACY OF PANAVIR® AND ACYCLOVIR IN THE COMPLEX THERAPY OF HERPETIC INFECTION-COMPLICATED RHEUMATOID ARTHRITIS

By O N Egorova, R M Balabanova, N E Lopatina, A K Kaptayeva, T P Fedina, E G Sazhina, E L Nasonov and G N Chuvirov

Abstract

Objective: to evaluate the efficiency of antiviral therapy in patients with herpetic infection-complicated rheumatoid arthritis (RA) who receive the basic therapy. Subjects and methods. One hundred and thirty patients with recurrent herpesvirus infection were enrolled in the prospective comparative study. The patients were divided into 3 groups: 1) in addition to the basic therapy, the patients received Panavir®; 2) those who took Acyclovir; and 3) those who had the basic therapy alone. In 90 of the 130 examinees, high titers of antiviral IgG antibodies to cytomegalovirus and Epstein-Barr virus were found in 60 and 48,8%, respectively. The interferon-deficiency syndrome was diagnosed in 72 (80,0%) patients. Results. Virostatic therapy may be recommended for patients with RA concurrent with recurrent herpesvirus infection

Topics: ревматоидный артрит, герпесвирусы, Панавир®, Ацикловир, Medicine, R
Publisher: IMA-PRESS LLC
Year: 2009
OAI identifier: oai:doaj.org/article:1fd39260a2e04881858b68489e728be5
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2310-158X (external link)
  • https://doaj.org/toc/1996-7012 (external link)
  • http://mrj.ima-press.net/mrj/a... (external link)
  • https://doaj.org/article/1fd39... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.